Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 14 pseudogene 19 (SEPTIN14P19) is a noncoding genomic locus with high sequence similarity to the SEPTIN14 gene, which encodes a member of the septin family involved in cytoskeletal organization. As a pseudogene, SEPTIN14P19 does not produce a functional protein due to disabling mutations or lack of critical regulatory elements. Pseudogenes such as SEPTIN14P19 may still be transcribed and can play roles in gene regulation, including acting as microRNA decoys or influencing RNA stability of functional paralogs or parent genes. However, there is no evidence for direct involvement in signal transduction, disease mechanisms, or drug interactions specific to SEPTIN14P19. Its function, if any, would be limited to noncoding RNA regulatory activities as described for other pseudogenes[1][3].
None applicable. Pseudogenes do not serve as therapeutic targets for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 14 pseudogene 19 (SEPTIN14P19).